| Autor: |
Glancy P; Department of Clinical Haematology Newcastle Upon Tyne Hospitals NHS Foundation Trust Newcastle Upon Tyne UK., Sutton DJ; Department of Clinical Haematology University Hospitals of North Midlands Stoke-on-Trent UK., Gomez K; Haemophilia Centre and Thrombosis Unit Royal Free Hospital London NHS Foundation Trust London UK., Nicolson PLR; Institute of Cardiovascular Sciences University of Birmingham College of Medical and Dental Sciences Birmingham UK., Buka RJ; Institute of Cardiovascular Sciences University of Birmingham College of Medical and Dental Sciences Birmingham UK. |
| Jazyk: |
angličtina |
| Zdroj: |
EJHaem [EJHaem] 2023 Jan 24; Vol. 4 (1), pp. 298-300. Date of Electronic Publication: 2023 Jan 24 (Print Publication: 2023). |
| DOI: |
10.1002/jha2.648 |
| Abstrakt: |
Competing Interests: Phillip L. R. Nicolson has received research grants from Novartis, Principia, Sanofi, AstraZeneca and Rigel Pharmaceuticals. Phillip L. R. Nicolson has had honoraria from Bayer, Grifols and Takeda. David J. Sutton has received honoraria from Bayer and Bristol Myers Squibb. Richard J. Buka has received research funding from AstraZeneca. The rest of the authors have no conflict of interest. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Plný text